37,117 Shares in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Acquired by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. purchased a new position in shares of Tevogen Bio Holdings Inc. (NASDAQ:TVGN) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 37,117 shares of the company’s stock, valued at approximately $38,000.

Separately, HGC Investment Management Inc. bought a new position in shares of Tevogen Bio in the 3rd quarter valued at $82,000.

Tevogen Bio Trading Up 0.7 %

Shares of TVGN opened at $1.47 on Wednesday. Tevogen Bio Holdings Inc. has a 52-week low of $0.26 and a 52-week high of $21.09. The business’s fifty day moving average is $1.21 and its 200-day moving average is $1.04.

Tevogen Bio Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.